HPA2b inhibitors belong to a specialized class of compounds that modulate the activity of a specific enzyme or protein, often associated with biological processes involving hydrolytic reactions. These inhibitors typically function by binding to the active or allosteric sites of HPA2b, preventing the normal enzymatic function, such as the breakdown of particular substrates. Structurally, HPA2b inhibitors can vary, with some being small organic molecules while others may be larger, more complex entities. Their binding interactions with the target protein can involve hydrophobic contacts, hydrogen bonding, or even covalent modifications, depending on the specific nature of the inhibitor. As a result, these compounds can be fine-tuned to have varying degrees of specificity and affinity toward HPA2b.
In terms of chemical properties, HPA2b inhibitors are designed to maintain stability under physiological conditions, exhibiting resistance to hydrolysis or oxidation. They can be synthesized using various organic chemistry methodologies, often involving multiple steps to achieve the precise structural configurations needed for effective inhibition. Additionally, their solubility, molecular weight, and lipophilicity are key factors that are considered during the design and synthesis process, ensuring that these compounds can effectively interact with the target enzyme in relevant biological environments. Moreover, these inhibitors may display a range of binding kinetics, from fast and reversible binding to slow, sustained interactions, which can influence their overall inhibitory profile.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Tyrosine kinase inhibitor, could potentially affect signaling pathways involved in cell growth and differentiation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src family kinase inhibitor, might influence cell adhesion and migration processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, could disrupt signaling pathways important for cell survival and proliferation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, potentially affecting the MAPK/ERK pathway, which could be relevant to "HPA2b" functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, might modulate stress response pathways and apoptosis related to "HPA2b" activity. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
p38 MAPK inhibitor, could affect inflammatory response pathways "HPA2b" might be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, might alter cellular growth and autophagy processes associated with "HPA2b." | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, could impact protein degradation pathways relevant to "HPA2b's" function. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates NF-κB and other signaling molecules, potentially affecting inflammation and cell growth. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways, could enhance cellular stress responses and affect "HPA2b" indirectly. | ||||||